| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |



||
From the Department of Gastroenterology*
and
Institute of Pathology,
University Hospital
Benjamin Franklin, Free University; Berlin; the Department of
Gastroenterology,
University of Erlangen,
Erlangen; the Department of Internal Medicine
II,§
University Hospital, Homburg/Saar; the
Institute of Pathology,¶
University of Freiburg
im Breisgau; and the Institute of Pathology,||
University Hospital Eppendorf, Hamburg, Germany
Collagenous colitis is characterized by the deposition of a
superficial subepithelial collagenous layer, the pathogenesis
of which is unknown. Because the excess matrix deposition is
potentially reversible, a labile imbalance between fibrogenesis
and fibrolysis may be suspected. Expression of procollagen
1(I) and
1(IV), matrix-metalloproteinase (MMP)-1 and -13, and
tissue inhibitor of metalloproteinase (TIMP)-1 genes was
semiquantitated by in situ hybridization on serial biopsies
of 12 patients with collagenous colitis and compared to controls.
Collagen types I, III, IV, and VI,
tenascin, undulin/collagen XIV, and
-actin were
localized by immunohistology. The superficial collagen layer stained
strongly for collagen types I, III, and VI, and
particularly for tenascin, but not for undulin. Elevated
procollagen
1(I), procollagen
1(IV), and TIMP-1
transcript levels were found in
-actin-positive cells with linear
distribution underneath the superficial collagenous layer,
whereas MMP-1 RNA expression was variable and restricted to cell
clusters. MMP-13 expression was undetectable. The patterns of
procollagen
1(I)- and
1(IV)-specific labeling, combined
with an intense tenascin- but absent undulin-specific staining,
indicate deposition of an immature interstitial matrix that may be
susceptible to degradation. The restricted MMP-1 RNA
expression, counteracted by increased TIMP-1
expression, suggests locally impaired fibrolysis as a relevant
factor in the pathogenesis of collagenous colitis.
This article has been cited by other articles:
![]() |
C. Medina and M. W. Radomski Role of Matrix Metalloproteinases in Intestinal Inflammation J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 933 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Whiting, J. F. Tarlton, M. Bailey, C. L. Morgan, and P. W. Bland Abnormal Mucosal Extracellular Matrix Deposition Is Associated with Increased TGF-{beta} Receptor-expressing Mesenchymal Cells in a Mouse Model of Colitis J. Histochem. Cytochem., September 1, 2003; 51(9): 1177 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Stallmach, C C Chan, K-W Ecker, G Feifel, H Herbst, D Schuppan, and M Zeitz Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis Gut, September 1, 2000; 47(3): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
D SCHUPPAN and E G HAHN MMPs in the gut: inflammation hits the matrix Gut, July 1, 2000; 47(1): 12 - 14. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |